Jul 27, 2021
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.02 to $0.35.
The split itself did not change the total investment value.
CLARITAS PHARMACEUTICALS INC. (OTC:CLAZF) operates in the Biotechnology industry.
CLARITAS PHARMACEUTICALS INC. company overviewCLARITAS PHARMACEUTICALS INC.'s most recent stock split was on July 27, 2021. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
CLARITAS PHARMACEUTICALS INC. (OTC:CLAZF) has split its stock 5 times: a 1-for-2 reverse split on April 21, 2009, a 1-for-10 reverse split on June 13, 2012, a 1-for-12 reverse split on April 6, 2016, a 10-for-23 reverse split on January 11, 2017, and a 1-for-20 reverse split on July 27, 2021.
CLARITAS PHARMACEUTICALS INC. has split its stock 5 times. This history records 5 reverse splits between April 21, 2009 and July 27, 2021.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In CLARITAS PHARMACEUTICALS INC.'s 1-for-20 reverse split on July 27, 2021, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
CLARITAS PHARMACEUTICALS INC. has not announced a new split in our records. Its most recent split was on July 27, 2021, 5 years ago. Companies announce splits in advance, and any new OTC:CLAZF split will appear on this page.